Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 OctoPlus In Specialty Generic Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

OctoPlus In Specialty Generic Pact

Will develop a generic copy for small-scale production

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

OctoPlus N.V. has signed a feasibility agreement with a leading generics company to develop a generic formulation of an existing injectable specialty pharmaceutical product. OctoPlus will develop a generic copy the injectable specialty pharmaceutical for small-scale production. If the project is successful, the contract may expand to a full process development and manufacturing agreement. Financial terms were not disclosed.

Jan Egberts, chief executive officer of OctoPlus, said, “Development of complex long-acting generic products, so-called specialty generics, is a strategic focus for OctoPlus. Our expertise in the development of these formulations is unique, and the combination of our formulation development and our manufacturing expertise really fits our sweet spot. This is the second specialty generic project which we have initiated and we look forward to putting our expertise to use for this project.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics